Ligand validation:4QFY

DGT: 2'-DEOXYGUANOSINE-5'-TRIPHOSPHATE

DGT is a Ligand Of Interest in 4QFY designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4QFY_DGT_D_701	85%	22%	0.105	0.972	2.02	1.26	7	6	1	0	100%	1
4QFY_DGT_A_704	85%	21%	0.103	0.969	2.01	1.35	7	4	0	0	100%	0.95
4QFY_DGT_B_702	82%	22%	0.113	0.969	2.04	1.22	8	3	0	0	100%	0.94
4QFY_DGT_C_702	80%	20%	0.12	0.968	1.98	1.45	6	6	2	0	100%	0.99
4QFY_DGT_A_701	78%	21%	0.125	0.967	2.04	1.27	7	3	1	0	100%	0.99
4QFY_DGT_C_701	77%	23%	0.116	0.956	1.98	1.23	7	3	1	0	100%	0.97
4QFY_DGT_C_703	76%	19%	0.126	0.963	2.05	1.41	7	5	0	0	100%	0.88
4QFY_DGT_A_703	75%	21%	0.131	0.963	2.02	1.31	7	6	0	0	100%	0.88
7LTT_DGT_D_800	95%	45%	0.084	0.988	1.04	1.07	2	4	0	0	100%	1
4BZB_DGT_B_700	93%	44%	0.071	0.965	0.88	1.27	1	6	0	0	100%	1
4MZ7_DGT_A_704	91%	42%	0.091	0.979	0.98	1.27	1	4	0	0	100%	1
4TO4_DGT_D_702	85%	41%	0.113	0.979	0.97	1.32	2	6	0	0	100%	1
4TO3_DGT_C_701	85%	33%	0.116	0.982	1.31	1.34	1	5	0	0	100%	1
3F2C_DGT_A_1456	99%	30%	0.06	0.989	0.96	1.8	1	6	3	0	100%	1
7U78_DGT_A_506	98%	44%	0.052	0.974	0.95	1.21	3	3	1	0	100%	0.85
3F2D_DGT_A_1456	98%	29%	0.065	0.985	0.96	1.84	-	7	3	0	100%	1
1XJJ_DGT_A_1001	98%	21%	0.064	0.983	1.71	1.63	4	8	0	0	100%	1
3B0Y_DGT_A_576	98%	47%	0.066	0.985	0.86	1.17	-	2	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.